Celldex Therapeutics (CLDX) Insider Trading & Ownership $22.46 -0.13 (-0.58%) Closing price 04:00 PM EasternExtended Trading$22.50 +0.04 (+0.18%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Celldex Therapeutics (NASDAQ:CLDX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$308,430.00Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$9.16 M Get CLDX Insider Trade Alerts Want to know when executives and insiders are buying or selling Celldex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CLDX Insider Buying and Selling by Quarter Celldex Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Anthony S MarucciCEOBuy11,500$26.82$308,430.00 6/14/2024Elizabeth CrowleyVPSell30,000$34.87$1,046,100.00 6/14/2024Samuel Bates MartinCFOSell17,172$35.42$608,232.24 6/7/2024Diane C YoungSVPSell45,000$35.26$1,586,700.00 6/7/2024Elizabeth CrowleyVPSell15,000$35.06$525,900.00 6/3/2024Richard M WrightVPSell46,844$33.72$1,579,579.68 5/30/2024Elizabeth CrowleyVPSell38,597$33.64$1,298,403.08 5/30/2024Margo Heath-ChiozziSVPSell38,719$34.07$1,319,156.33 5/30/2024Samuel Bates MartinCFOSell35,000$34.05$1,191,750.00 (Data available from 1/1/2013 forward) CLDX Insider Trading Activity - Frequently Asked Questions Who is on Celldex Therapeutics's Insider Roster? The list of insiders at Celldex Therapeutics includes Anthony S Marucci, Diane C Young, Elizabeth Crowley, Margo Heath-Chiozzi, Richard M Wright, Samuel Bates Martin, and Sarah Cavanaugh. Learn more on insiders at CLDX. What percentage of Celldex Therapeutics stock is owned by insiders? 3.80% of Celldex Therapeutics stock is owned by insiders. Learn more on CLDX's insider holdings. Which Celldex Therapeutics insiders have been buying company stock? The following insider purchased CLDX shares in the last 24 months: Anthony S Marucci ($308,430.00). How much insider buying is happening at Celldex Therapeutics? Insiders have purchased a total of 11,500 CLDX shares in the last 24 months for a total of $308,430.00 bought. Which Celldex Therapeutics insiders have been selling company stock? The following insiders have sold CLDX shares in the last 24 months: Diane C Young ($1,586,700.00), Elizabeth Crowley ($2,870,403.08), Margo Heath-Chiozzi ($1,319,156.33), Richard M Wright ($1,579,579.68), and Samuel Bates Martin ($1,799,982.24). How much insider selling is happening at Celldex Therapeutics? Insiders have sold a total of 266,332 Celldex Therapeutics shares in the last 24 months for a total of $9,155,821.33 sold. Celldex Therapeutics Key ExecutivesMr. Anthony S. Marucci M.B.A. (Age 62)Founder, President, CEO & Director Compensation: $1.27M1 recent tradesDr. Tibor Keler Ph.D. (Age 65)Founder, Chief Scientific Officer & Executive VP Compensation: $810.39kMr. Sam Martin (Age 53)Senior VP, CFO, Secretary & Treasurer Compensation: $676.87kDr. Margo Heath-Chiozzi M.D. (Age 67)Senior Vice President of Regulatory Affairs Compensation: $667.21kDr. Diane C. Young M.D. (Age 67)Senior VP & Chief Medical Officer Compensation: $696.45kProf. Joseph P. Schlessinger Ph.D. (Age 79)Co-Founder & Member of Scientific Advisory Board Ms. Sarah Cavanaugh (Age 49)Senior Vice President of Corporate Affairs & Administration Mr. Freddy A. Jimenez Esq. (Age 55)Senior VP & General Counsel Compensation: $579.7kDr. Ronald A. Pepin (Age 68)Chief Business Officer & Senior VP Compensation: $441.84kMs. Elizabeth Crowley (Age 52)Chief Product Development Officer & Senior VP Compensation: $507.24k More Insider Trading Tools from MarketBeat Related Companies ALKS Insider Transactions IONS Insider Transactions FOLD Insider Transactions LGND Insider Transactions BCRX Insider Transactions DVAX Insider Transactions GERN Insider Transactions MNKD Insider Transactions MYGN Insider Transactions NVAX Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:CLDX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celldex Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celldex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
